Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Building Materials

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

Revenue projections:

Revenue projections for AMBUJACEM
Revenue projections for AMBUJACEM

Revenues for Ambuja Cements Limited are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 1.424000
forwardPE 28.911345
debtToEquity 1.236000
earningsGrowth -0.187000
revenueGrowth 0.112000
grossMargins 0.558840
operatingMargins 0.110510
trailingEps 16.980000
forwardEps 0.000000

AMBUJACEM's current ratio of 1.424 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring AMBUJACEM is unlikely to face difficulties in meeting immediate financial obligations.
AMBUJACEM's Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
AMBUJACEM's low earnings and revenue growth highlight a potential decline in profitability. This suggests that the company's financial health may be weakening, and profits could shrink as a result.
AMBUJACEM's negative gross and operating margins point to financial difficulties, as the company is incurring losses at both the production and operational levels. This suggests a potential decline in profitability and raises concerns about its financial outlook.

Price projections:

Price projections for AMBUJACEM
Price projections for AMBUJACEM

AMBUJACEM's stock price has repeatedly hovered near the lower end of projections. This trend indicates that the company may be facing obstacles in achieving the growth anticipated by analysts.

Recommendation changes over time:

Recommendations trend for AMBUJACEM
Recommendations trend for AMBUJACEM


AMBUJACEM has recently received a buy bias from analysts, indicating that the stock is being perceived as a favorable investment. This positive sentiment could encourage investors to see AMBUJACEM as a wise place to allocate their funds, potentially leading to increased interest in the company's stock.